Rapid Radiographic and Clinical Improvement After Treatment of a MET-Amplified Recurrent Glioblastoma With a Mesenchymal-Epithelial Transition Inhibitor

被引：81

作者：

Chi, Andrew S. ^{[1
]}

Batchelor, Tracy T. ^{[1
]}

Kwak, Eunice L. ^{[1
]}

Clark, Jeffrey W. ^{[1
]}

Wang, Daphne L. ^{[1
]}

Wilner, Keith D. ^{[2
]}

Louis, David N. ^{[1
]}

Iafrate, A. John ^{[1
]}

机构：

[1] Harvard Univ, Massachusetts Gen Hosp, Ctr Canc, Sch Med, Boston, MA 02114 USA

[2] Pfizer, New York, NY USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 03期

关键词：

FACTOR/HEPATOCYTE GROWTH-FACTOR; TYROSINE KINASE INHIBITOR; CELL LUNG-CANCER; C-MET; ANAPLASTIC LYMPHOMA; EXPRESSION; AMPLIFICATION; TUMORS; PF-2341066; CRIZOTINIB;

D O I：

10.1200/JCO.2011.38.4586

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：E30 / E33

页数：4

共 30 条

[1] Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression [J].

Abounader, R ;

Ranganathan, S ;

Lal, B ;

Fielding, K ;

Book, A ;

Dietz, H ;

Burger, P ;

Laterra, J .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (18) :1548-1556

[2] In vivo targeting of SF/HGF and c-met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis [J].

Abounader, R ;

Lal, B ;

Luddy, C ;

Koe, G ;

Davidson, B ;

Rosen, EM ;

Laterra, J .

FASEB JOURNAL, 2001, 15 (13) :108-+

[3] AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients [J].

Batchelor, Tracy T. ;

Sorensen, A. Gregory ;

di Tomaso, Emmanuelle ;

Zhang, Wei-Ting ;

Duda, Dan G. ;

Cohen, Kenneth S. ;

Kozak, Kevin R. ;

Cahill, Daniel P. ;

Chen, Poe-Jou ;

Zhu, Mingwang ;

Ancukiewicz, Marek ;

Mrugala, Maciej M. ;

Plotkin, Scott ;

Drappatz, Jan ;

Louis, David N. ;

Ivy, Percy ;

Scadden, David T. ;

Benner, Thomas ;

Loeffler, Jay S. ;

Wen, Patrick Y. ;

Jain, Rakesh K. .

CANCER CELL, 2007, 11 (01) :83-95

[4] Comprehensive genomic characterization defines human glioblastoma genes and core pathways [J].

Chin, L. ;

Meyerson, M. ;

Aldape, K. ;

Bigner, D. ;

Mikkelsen, T. ;

VandenBerg, S. ;

Kahn, A. ;

Penny, R. ;

Ferguson, M. L. ;

Gerhard, D. S. ;

Getz, G. ;

Brennan, C. ;

Taylor, B. S. ;

Winckler, W. ;

Park, P. ;

Ladanyi, M. ;

Hoadley, K. A. ;

Verhaak, R. G. W. ;

Hayes, D. N. ;

Spellman, Paul T. ;

Absher, D. ;

Weir, B. A. ;

Ding, L. ;

Wheeler, D. ;

Lawrence, M. S. ;

Cibulskis, K. ;

Mardis, E. ;

Zhang, Jinghui ;

Wilson, R. K. ;

Donehower, L. ;

Wheeler, D. A. ;

Purdom, E. ;

Wallis, J. ;

Laird, P. W. ;

Herman, J. G. ;

Schuebel, K. E. ;

Weisenberger, D. J. ;

Baylin, S. B. ;

Schultz, N. ;

Yao, Jun ;

Wiedemeyer, R. ;

Weinstein, J. ;

Sander, C. ;

Gibbs, R. A. ;

Gray, J. ;

Kucherlapati, R. ;

Lander, E. S. ;

Myers, R. M. ;

Perou, C. M. ;

McLendon, Roger .

NATURE, 2008, 455 (7216) :1061-1068

[5] Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma [J].

Christensen, James G. ;

Zou, Helen Y. ;

Arango, Maria E. ;

Li, Qiuhua ;

Lee, Joseph H. ;

McDonnell, Scott R. ;

Yamazaki, Shinji ;

Alton, Gordon R. ;

Mroczkowski, Barbara ;

Los, Gerrit .

MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) :3314-3322

[6] c-Met-targeted RNA interference inhibits growth and metastasis of glioma U251 cells in vitro [J].

Chu, Sheng-Hua ;

Feng, Dong-Fu ;

Zhang, Hong ;

Chen, Er-Tao ;

Duan, Zhi-Xin ;

Li, Xue-Yuan ;

Li, Jia ;

Ma, Yan-Bin ;

Zhu, Zhi-An ;

Qiu, Jian-Hua .

JOURNAL OF NEURO-ONCOLOGY, 2009, 93 (02) :183-189

[7] Drug development of MET inhibitors: targeting oncogene addiction and expedience [J].

Comoglio, Paolo M. ;

Giordano, Silvia ;

Trusolino, Livio .

NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (06) :504-516

[8] CSF Concentration of the Anaplastic Lymphoma Kinase Inhibitor Crizotinib [J].

Costa, Daniel B. ;

Kobayashi, Susumu ;

Pandya, Shuchi S. ;

Yeo, Wee-Lee ;

Shen, Zhongzhou ;

Tan, Weiwei ;

Wilner, Keith D. .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15) :E443-E445

[9] Glioblastoma Recurrence after Cediranib Therapy in Patients: Lack of "Rebound" Revascularization as Mode of Escape [J].

di Tomaso, Emmanuelle ;

Snuderl, Matija ;

Kamoun, Walid S. ;

Duda, Dan G. ;

Auluck, Pavan K. ;

Fazlollahi, Ladan ;

Andronesi, Ovidiu C. ;

Frosch, Matthew P. ;

Wen, Patrick Y. ;

Plotkin, Scott R. ;

Hedley-Whyte, E. Tessa ;

Sorensen, A. Gregory ;

Batchelor, Tracy T. ;

Jain, Rakesh K. .

CANCER RESEARCH, 2011, 71 (01) :19-28

[10] Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine [J].

Dias-Santagata, Dora ;

Akhavanfard, Sara ;

David, Serena S. ;

Vernovsky, Kathy ;

Kuhlmann, Georgiana ;

Boisvert, Susan L. ;

Stubbs, Hannah ;

McDermott, Ultan ;

Settleman, Jeffrey ;

Kwak, Eunice L. ;

Clark, Jeffrey W. ;

Isakoff, Steven J. ;

Sequist, Lecia V. ;

Engelman, Jeffrey A. ;

Lynch, Thomas J. ;

Haber, Daniel A. ;

Louis, David N. ;

Ellisen, Leif W. ;

Borger, Darrell R. ;

Lafrate, A. John .

EMBO MOLECULAR MEDICINE, 2010, 2 (05) :146-158

← 1 2 3 →